Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 683

The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.

Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling

Open access
Jones, Simon A., Scheller, Jürgen, Rose-John, Stefan·2011·Journal of Clinical Investigation

Abstract

The successful treatment of certain autoimmune conditions with the humanized anti-IL-6 receptor (IL-6R) antibody tocilizumab has emphasized the clinical importance of cytokines that signal through the β-receptor subunit glycoprotein 130 (gp130).In this Review, we explore how gp130 signaling controls disease progression and examine why IL-6 has a special role among these cytokines as an inflammatory regulator.Attention will be given to the role of the soluble IL-6R, and we will provide a perspective into the clinical blockade of IL-6 activity in autoimmunity, inflammation, and cancer.Conflict of interest: Stefan Rose-John is an inventor on the patent describing the function of sgp130Fc.He is also a shareholder of the CONARIS Research Institute (Kiel, Germany), which is commercially developing sgp130Fc as a therapy for inflammatory diseases.Simon A. Jones has a consultancy agreement with Roche Pharmaceuticals and advises research relating to the clinical introduction of Actemra/RoActemra.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci57158

Cites

125 of 125 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 125 references

Cited by

See all 683

Metadata

Authors
Jones, S. A., Scheller, J., & Rose-John, S.
Venue
Journal of Clinical Investigation
Published
2011-09-01
Volume
121
Issue
9
Pages
3375-3383
ISSN
0021-9738 (ISSN-L)
OpenAlex
W1971308765
Cited by
683
References
125
FWCI
25.37
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling. https://app.cochat.ai/papers/10.1172/jci57158
The paper
Jones, S. A., Scheller, J., & Rose-John, S. (2011). Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling. Journal of Clinical Investigation. https://doi.org/10.1172/jci57158

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.